PTC Total Stockholder Equity vs Capital Surpluse Analysis

PTCT Stock  USD 43.23  0.34  0.79%   
PTC Therapeutics financial indicator trend analysis is much more than just breaking down PTC Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PTC Therapeutics is a good investment. Please check the relationship between PTC Therapeutics Total Stockholder Equity and its Capital Surpluse accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PTC Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy PTC Stock please use our How to Invest in PTC Therapeutics guide.

Total Stockholder Equity vs Capital Surpluse

Total Stockholder Equity vs Capital Surpluse Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PTC Therapeutics Total Stockholder Equity account and Capital Surpluse. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between PTC Therapeutics' Total Stockholder Equity and Capital Surpluse is -0.29. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of PTC Therapeutics, assuming nothing else is changed. The correlation between historical values of PTC Therapeutics' Total Stockholder Equity and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of PTC Therapeutics are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Total Stockholder Equity i.e., PTC Therapeutics' Total Stockholder Equity and Capital Surpluse go up and down completely randomly.

Correlation Coefficient

-0.29
Relationship DirectionNegative 
Relationship StrengthInsignificant

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Capital Surpluse

Most indicators from PTC Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PTC Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PTC Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy PTC Stock please use our How to Invest in PTC Therapeutics guide.At this time, PTC Therapeutics' Selling General Administrative is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.80 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (11.75) in 2024.
 2021 2022 2023 2024 (projected)
Research Development540.7M651.5M666.6M699.9M
Total Revenue538.6M698.8M937.8M984.7M

PTC Therapeutics fundamental ratios Correlations

0.840.89-0.240.810.660.770.920.650.670.430.920.780.650.840.270.48-0.870.910.610.880.860.880.920.90.28
0.840.86-0.560.390.410.60.730.860.290.820.910.620.850.87-0.160.78-0.910.650.190.610.910.70.750.950.23
0.890.86-0.630.580.520.80.840.860.410.50.980.920.860.940.320.72-0.970.730.60.690.960.750.830.960.26
-0.24-0.56-0.630.160.0-0.24-0.31-0.790.23-0.57-0.6-0.57-0.78-0.67-0.01-0.840.65-0.04-0.09-0.01-0.63-0.11-0.23-0.61-0.09
0.810.390.580.160.610.550.820.170.83-0.090.60.620.180.520.580.02-0.480.880.790.820.490.690.750.560.21
0.660.410.520.00.610.540.660.140.490.040.540.60.170.580.4-0.01-0.560.730.640.570.590.710.750.50.3
0.770.60.8-0.240.550.540.620.590.450.150.730.780.610.640.440.32-0.750.680.640.690.730.770.780.670.33
0.920.730.84-0.310.820.660.620.590.780.380.880.80.610.880.350.49-0.820.80.680.870.780.750.840.870.22
0.650.860.86-0.790.170.140.590.590.140.770.850.651.00.81-0.090.95-0.880.350.160.460.840.510.550.870.18
0.670.290.410.230.830.490.450.780.140.010.460.420.170.420.370.03-0.350.580.60.870.270.560.570.430.17
0.430.820.5-0.57-0.090.040.150.380.770.010.590.170.750.6-0.640.83-0.620.15-0.340.280.590.320.340.670.12
0.920.910.98-0.60.60.540.730.880.850.460.590.870.860.960.220.74-0.980.760.540.720.960.760.850.990.26
0.780.620.92-0.570.620.60.780.80.650.420.170.870.670.880.630.5-0.860.710.830.610.850.660.760.810.21
0.650.850.86-0.780.180.170.610.611.00.170.750.860.670.83-0.060.94-0.890.350.190.480.840.520.560.870.2
0.840.870.94-0.670.520.580.640.880.810.420.60.960.880.830.220.74-0.960.680.530.660.940.70.790.960.22
0.27-0.160.32-0.010.580.40.440.35-0.090.37-0.640.220.63-0.060.22-0.24-0.160.420.910.270.170.220.310.110.1
0.480.780.72-0.840.02-0.010.320.490.950.030.830.740.50.940.74-0.24-0.760.17-0.020.30.720.310.370.780.08
-0.87-0.91-0.970.65-0.48-0.56-0.75-0.82-0.88-0.35-0.62-0.98-0.86-0.89-0.96-0.16-0.76-0.7-0.48-0.67-0.99-0.78-0.84-0.97-0.26
0.910.650.73-0.040.880.730.680.80.350.580.150.760.710.350.680.420.17-0.70.70.770.740.850.910.730.27
0.610.190.6-0.090.790.640.640.680.160.6-0.340.540.830.190.530.91-0.02-0.480.70.590.480.540.630.450.15
0.880.610.69-0.010.820.570.690.870.460.870.280.720.610.480.660.270.3-0.670.770.590.610.860.850.70.22
0.860.910.96-0.630.490.590.730.780.840.270.590.960.850.840.940.170.72-0.990.740.480.610.780.840.950.27
0.880.70.75-0.110.690.710.770.750.510.560.320.760.660.520.70.220.31-0.780.850.540.860.780.930.730.19
0.920.750.83-0.230.750.750.780.840.550.570.340.850.760.560.790.310.37-0.840.910.630.850.840.930.820.44
0.90.950.96-0.610.560.50.670.870.870.430.670.990.810.870.960.110.78-0.970.730.450.70.950.730.820.27
0.280.230.26-0.090.210.30.330.220.180.170.120.260.210.20.220.10.08-0.260.270.150.220.270.190.440.27
Click cells to compare fundamentals

PTC Therapeutics Account Relationship Matchups

PTC Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.6B2.2B1.9B1.7B1.9B2.0B
Other Current Liab197.3M232.7M60.8M348.2M385.9M405.2M
Total Current Liabilities235.9M277.3M509.3M406.2M603.1M633.3M
Total Stockholder Equity594.3M482.0M1.4M(347.1M)(818.6M)(777.6M)
Other Liab490.7M1.0B1.1B269.5M309.9M263.2M
Accounts Payable10.3M18.7M23.0M27.3M6.0M9.9M
Cash686.6M208.8M773.4M410.7M594.0M623.7M
Other Assets16.4M60.6M46.5M33.4M38.4M40.3M
Long Term Debt293.9M309.1M281.9M571.7M1.9B2.0B
Short Term Investments398.5M894.8M583.7M130.9M282.7M281.6M
Other Current Assets17.9M78.9M(126.3M)105.7M150.3M157.8M
Total Liab1.0B1.7B1.9B2.1B2.7B2.8B
Property Plant Equipment21.5M33.8M130.0M72.6M83.5M87.7M
Short Long Term Debt Total313.9M420.4M441.7M703.6M2.2B2.3B
Property Plant And Equipment Net21.5M118.2M130.0M175.0M179.0M187.9M
Current Deferred Revenue8.2M4.2M265.8M1.4M801K761.0K
Net Debt(372.7M)211.6M(341.9M)292.9M1.6B1.7B
Retained Earnings(1.2B)(1.6B)(2.1B)(2.7B)(3.3B)(3.1B)
Non Current Assets Total844.5M976.5M1.2B1.0B677.1M479.9M
Non Currrent Assets Other30.1M60.6M227.5M48.6M36.2M34.8M
Cash And Short Term Investments686.6M1.1B773.4M410.7M876.7M450.9M
Net Receivables55.5M69.9M110.5M155.6M161.0M169.1M
Common Stock Total Equity62K70K71K72K82.8K45.3K
Common Stock Shares Outstanding58.9M66.0M70.5M71.7M74.8M49.7M
Liabilities And Stockholders Equity1.6B2.2B1.9B1.7B1.9B1.0B
Non Current Liabilities Total793.6M1.4B1.2B1.6B2.1B2.2B
Other Stockholder Equity1.8B2.2B2.1B2.3B2.5B2.6B
Property Plant And Equipment Gross21.5M118.2M157.2M212.4M230.3M241.8M
Total Current Assets779.3M1.2B773.4M693.8M1.2B1.3B
Accumulated Other Comprehensive Income(10.6M)(61.0M)(24.3M)4.8M(1.3M)(1.3M)
Short Term Debt20M17.5M159.8M24.7M210.3M220.8M
Common Stock62K70K71K72K75K48.1K
Net Tangible Assets(198.5M)(315.7M)(805.7M)(1.1B)(1.0B)(970.7M)
Retained Earnings Total Equity(1.2B)(1.6B)(2.1B)(2.7B)(2.4B)(2.3B)
Capital Surpluse1.8B2.2B2.1B2.3B2.7B1.6B
Inventory19.3M18.7M15.9M21.8M30.6M32.1M
Deferred Long Term Liab130.9M136.7M137.1M102.8M118.3M70.3M
Non Current Liabilities Other368.9M1.0B1.0B971.9M141K134.0K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for PTC Stock Analysis

When running PTC Therapeutics' price analysis, check to measure PTC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PTC Therapeutics is operating at the current time. Most of PTC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PTC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PTC Therapeutics' price. Additionally, you may evaluate how the addition of PTC Therapeutics to your portfolios can decrease your overall portfolio volatility.